Answers are grounded in this paper and cite their sources.
Vascular wilts are among the most ubiquitous and difficult to manage diseases. For effective control, a treatment must control the disease at the root surface and help plant maintain its functions post exposure to the pathogen. Chitosan nanoparticles (CNPs) have become under the limelight because they potentially are antipathogenic, stimulate host defenses, and are carrier of active compounds. This critical narrative review examines original research articles published in the last ten years to examine if CNPs reported effects translate into substantial plant protection. The review is primarily concerned with the wilt diseases including bacterial (Ralstonia solanaceraum), Verticillium, and Fusarium wilt. The studies pertaining to CNPs loaded with thiamine, botanical extracts, and salicylic acid report promising results. However, variable results have been obtained due to variable formulations and host genotype. Moreover, symptoms can decline while infection persists, whereas field experiments are scarce in this regard. Differences in composition and disease measurement also prevent a meaningful pooled estimate of efficacy. Evidence of altered nodulation, mycorrhization and crop injury raises a further concern: biodegradability of the polymer alone says little about the environmental performance of the finished product. The next stage of research should establish what complete formulations contribute beyond their individual components and whether disease and yield benefits persist in the field at acceptable cost and exposure. CNPs merit further development within integrated wilt management, but their value must be demonstrated for each formulation and crop–pathogen combination.
No takes yet. Share an insight, caveat, or question.
Muhammad Ibrahim Tahir (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: